Health Condition 1: H119- Unspecified disorder of conjunctiva
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: •Males & Females with age 30â??60 year •Subjects able to provide informed consent. •Patient is willing and able to comply with all trial requirements •Subjects is having at least anyone of the following condition- Eye strain / redness / watering / burning sensation / itching in the eyes / acuity of vision.
Exclusion criteria
Exclusion criteria: •Subject has had the crystalline lens removed from the study eye or has had the crystalline lens removed and replaced with an intraocular lens (IOL) implant in the left eye. •Subject has been clinically diagnosed with cataracts in the study eye. •Subject has had a fluorescence angiogram within the last six months. •Pregnant or lactating women •Subject has undergone a treatment using photodynamic drugs within the last year. •Subject has Type I or II diabetes or is not deemed healthy from Demographic and Health Questionnaire or the comprehensive eye exam. •Subject was fit with contact lens within the last 30 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢Changes in visual capacity evaluated by standard comprehensive ophthalmic examination (Snellen test). â?¢Changes in eye conditions like Eye strain / redness / watering / burning sensation / itching in the eye. Timepoint: Screening to EOT (Day 90) | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Incidence and rate of adverse eventsTimepoint: Screening to EOT (Day 90) | — |
Countries
India
Contacts
ICBio Clinical Research Pvt. Ltd.